Maximum Dose of Citalopram
The maximum recommended dose of citalopram is 40 mg per day for adults under 60 years of age, with reduced maximum doses of 20 mg per day for patients over 60 years, those with hepatic impairment, and CYP2C19 poor metabolizers, due to the risk of dose-dependent QT interval prolongation. 1
Standard Adult Dosing
- For adults under 60 years of age, the maximum dose is 40 mg per day 2, 1
- The FDA explicitly states that doses exceeding 40 mg per day are no longer considered safe due to dose-dependent QT interval prolongation 1, 3
- The typical starting dose is 20 mg once daily, which can be increased after 1-2 weeks if clinical response is insufficient 2
Age-Related Dose Restrictions
- For patients 60 years of age or older, the maximum dose is strictly limited to 20 mg per day 2, 1
- This restriction is based on pharmacokinetic data showing that citalopram AUC increases by 23-30% and half-life increases by 30-50% in elderly patients 1
- Elderly patients are at greater risk for hyponatremia and QT prolongation with SSRIs 1
Special Population Dose Restrictions (20 mg Maximum)
The following patient populations are restricted to a maximum of 20 mg per day due to increased QT prolongation risk:
- Hepatic impairment: Oral clearance is reduced by 37% and half-life is doubled 1
- CYP2C19 poor metabolizers: Steady-state Cmax and AUC increase by 68% and 107%, respectively 1
- Patients taking CYP2C19 inhibitors (such as cimetidine or omeprazole) 1
Critical Safety Considerations
- The QT prolongation risk is dose-dependent, with risk increasing substantially above 40 mg daily 2, 3
- A thorough QT/QTc study demonstrated statistically significant QT prolongation at doses exceeding 40 mg 3
- Post-marketing reports have documented cases of torsade de pointes in patients taking higher doses 3
Clinical Context of Dose Restrictions
- A large retrospective study of 35,848 veterans found that reducing citalopram doses from above 40 mg to ≤40 mg was associated with increased hospitalizations (adjusted hazard ratio 4.5) and hospitalizations for depression (adjusted hazard ratio 2.2), though this does not negate the cardiac safety concerns 4
- Efficacy studies demonstrate that 40 mg and 60 mg doses show robust antidepressant effects, but the cardiac risks at 60 mg outweigh potential benefits 5, 6
- Even 10-20 mg doses show antidepressant efficacy, though with lower effect sizes than 40 mg 6
Drug Interactions Requiring Dose Reduction
- Cimetidine: Maximum 20 mg daily due to CYP2C19 inhibition 1
- Omeprazole and other potent CYP2C19 inhibitors: Maximum 20 mg daily 1
- Ketoconazole (CYP3A4 inhibitor) does not significantly affect citalopram pharmacokinetics and does not require dose adjustment 1